PRT15 Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
Sat, Mar 28, 3:00 PM - 3:45 PM
Exhibit Hall - Theater 1
Product Theater
DESCRIPTION
This program will provide an insightful view of RHAPSIDO®, including mechanism of action with RHAPSIDO; demonstrated efficacy and safety data; and getting patients started on RHAPSIDO.
Presented by: Novartis Pharmaceuticals Corporation